AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 29 filers reported holding AGILE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,855,000 | -25.8% | 5,062,363 | 0.0% | 3.50% | -9.0% |
Q2 2018 | $2,501,000 | -80.8% | 5,062,363 | 0.0% | 3.85% | -74.3% |
Q1 2018 | $13,010,000 | -4.5% | 5,062,363 | 0.0% | 14.96% | -17.3% |
Q4 2017 | $13,617,000 | -39.7% | 5,062,363 | 0.0% | 18.09% | -20.0% |
Q3 2017 | $22,579,000 | +18.9% | 5,062,363 | 0.0% | 22.62% | -6.8% |
Q2 2017 | $18,984,000 | +16.8% | 5,062,363 | 0.0% | 24.27% | +396.6% |
Q1 2017 | $16,250,000 | -43.7% | 5,062,363 | 0.0% | 4.89% | -40.2% |
Q4 2016 | $28,856,000 | -18.3% | 5,062,363 | 0.0% | 8.17% | -16.1% |
Q3 2016 | $35,335,000 | -8.3% | 5,062,363 | 0.0% | 9.73% | -37.9% |
Q2 2016 | $38,525,000 | +22.5% | 5,062,363 | 0.0% | 15.67% | +28.3% |
Q1 2016 | $31,438,000 | -31.0% | 5,062,363 | +8.4% | 12.21% | +38.9% |
Q4 2015 | $45,566,000 | +44.8% | 4,668,663 | 0.0% | 8.79% | +18.1% |
Q3 2015 | $31,467,000 | -21.5% | 4,668,663 | 0.0% | 7.45% | -9.6% |
Q2 2015 | $40,104,000 | -7.3% | 4,668,663 | -0.0% | 8.24% | -41.7% |
Q1 2015 | $43,278,000 | +82.8% | 4,668,763 | +21.1% | 14.12% | +17.6% |
Q4 2014 | $23,680,000 | – | 3,856,697 | – | 12.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 42,588,970 | $20,788,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 733,685 | $358,000 | 0.04% |
INVESTOR AB | 3,510,189 | $1,720,000 | 0.04% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 350,000 | $171,000 | 0.02% |
Virtu Financial LLC | 237,642 | $116,000 | 0.01% |
FIRST MIDWEST BANK TRUST DIVISION | 160,980 | $79,000 | 0.01% |
Founders Capital Management | 20,000 | $10,000 | 0.01% |
Aquatic Capital Management LLC | 4,000 | $2,000 | 0.00% |
GRIMES & COMPANY, INC. | 84,378 | $41,000 | 0.00% |
Centric Wealth Management | 10,000 | $5,000 | 0.00% |